Psilocybin Therapy

                       

                                            

 Psychedelic therapy may be an uncommon practice, but it's lightyears away from the fringe.  Renowned organizations like John Hopkins Foundation and MAPS are leading mainstream conversations through successful psychedelic trials and research programs.  Simultaneously, legal ketamine clinics are actively treating depressed patients across the country.  The 'heal thyself' renaissance is underway, yet its future is still uncertain. 

Research success doesn't always align with practice results. That gap in outcomes, along with psychedelic misconceptions, could interfere with widespread acceptance. To convince the masses that psychedelic therapy is a mental-health innovation worth championing, clinicians must hold space for a data-driven treatment model.

Psychedelic therapy is undoubtedly the most promising new protocol for anxiety, depression and PTSD among other mental health issues. Still, psychedelics are not a panacea. They don't come wrapped in a standardized happiness package that works the same for everyone. Psychedelic therapist support is nearly just as crucial as plant medicine itself. That's why Ketamine clinicians, integration coaches, and even retreat facilitators need highly effective tools and strategies to create personalized plans for individual self-healing.

     

THE BOTTOM LINE

Using data gathered from other providers worldwide, psychedelic therapists and coaches are closing the gap between clinical research and real-world practice. They can also treat patients more mindfully and methodically, supporting people with greater efficiency on their journey to physical, mental, and emotional wellbeing. 

If you are curious about implementing MBC in your practice, we encourage you to explore ZenTrip1 as a platform to help with a seamless transition. Zentrip1 is offering practitioners and clinics 20% off and exclusive access before it's available to the public.